Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$554M |
| 2 |
Broadcom
AVGO
|
+$378M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$324M |
| 4 |
Warner Bros
WBD
|
+$321M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$454M |
| 2 |
iShares MBS ETF
MBB
|
+$441M |
| 3 |
AT&T
T
|
+$266M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$198M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.98% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
NI Holdings
NODK
$314M
| $376K | ﹤0.01% |
22,856
-1,228
| -5% | -$20.3K |
|
3152
Consumer Portfolio Services
CPSS
$208M
| $375K | ﹤0.01% |
+36,545
| New | +$445K |
|
3153
Vanguard International Dividend Appreciation ETF
VIGI
$9.15B
| $375K | ﹤0.01% |
5,464
-183
| -3% | -$13.4K |
|
3154
Dakota Gold
DC
$624M
| $374K | ﹤0.01% |
+111,602
| New | +$445K |
|
3155
Tenaya Therapeutics
TNYA
$163M
| $374K | ﹤0.01% |
66,338
-2,366
| -3% | -$19.1K |
|
|
JBIO
3156
Jade Biosciences
JBIO
$1.22B
| $373K | ﹤0.01% |
681
-258
| -27% | -$123K |
|
3157
Lifetime Brands
LCUT
$192M
| $373K | ﹤0.01% |
33,704
+824
| +3% | +$9.75K |
|
3158
ThredUp
TDUP
$757M
| $373K | ﹤0.01% |
149,040
+128,932
| +641% | +$696K |
|
|
CMLS
3159
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $372K | ﹤0.01% |
+48,027
| New | +$563K |
|
|
CNVY
3160
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $369K | ﹤0.01% |
35,449
+4,786
| +16% | +$29.7K |
|
3161
Crawford & Co Class A
CRD.A
$532M
| $367K | ﹤0.01% |
46,940
+10,215
| +28% | +$79.4K |
|
3162
Spire Global
SPIR
$440M
| $363K | ﹤0.01% |
39,115
+34,350
| +721% | +$440K |
|
3163
HighPeak Energy
HPK
$838M
| $361K | ﹤0.01% |
14,078
+2,113
| +18% | +$61.5K |
|
|
TIG
3164
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $361K | ﹤0.01% |
57,913
+17,109
| +42% | +$101K |
|
3165
Zeta Global
ZETA
$5.33B
| $353K | ﹤0.01% |
+77,879
| New | +$683K |
|
3166
Vanguard Morningstar Growth ETF
VUG
$218B
| $351K | ﹤0.01% |
+9,450
| New | +$388K |
|
3167
Torrid Holdings
CURV
$260M
| $350K | ﹤0.01% |
80,984
-15,426
| -16% | -$86.6K |
|
3168
NextDecade
NEXT
$1.78B
| $347K | ﹤0.01% |
77,945
+67,936
| +679% | +$421K |
|
3169
Precision BioSciences
DTIL
$181M
| $346K | ﹤0.01% |
7,208
-4,874
| -40% | -$286K |
|
3170
Aterian
ATER
$4.23M
| $345K | ﹤0.01% |
13,283
+6,554
| +97% | +$290K |
|
3171
Nautilus Biotechnolgy
NAUT
$131M
| $342K | ﹤0.01% |
127,006
+104,750
| +471% | +$390K |
|
|
PSTX
3172
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $342K | ﹤0.01% |
132,419
-87,671
| -40% | -$244K |
|
|
ALPN
3173
DELISTED
Alpine Immune Sciences Inc
ALPN
| $339K | ﹤0.01% |
39,823
+7,406
| +23% | +$63.8K |
|
3174
Outlook Therapeutics
OTLK
$194M
| $338K | ﹤0.01% |
16,549
+714
| +5% | +$20.5K |
|
3175
Taysha Gene Therapies
TSHA
$1.69B
| $338K | ﹤0.01% |
90,711
-74,634
| -45% | -$296K |
|
Similar funds
Charles Schwab's Q2 2022 Portfolio in Review
As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
- Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
- Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
- Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
- Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
- Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
- Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.
Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.